Cita APA (7a ed.)

Spoerke, J. M., Gendreau, S., Walter, K., Qiu, J., Wilson, T. R., Savage, H., . . . Lackner, M. R. (2016). Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant. Nature Portfolio.

Cita Chicago Style (17a ed.)

Spoerke, Jill M., et al. Heterogeneity and Clinical Significance of ESR1 Mutations in ER-positive Metastatic Breast Cancer Patients Receiving Fulvestrant. Nature Portfolio, 2016.

Cita MLA (8a ed.)

Spoerke, Jill M., et al. Heterogeneity and Clinical Significance of ESR1 Mutations in ER-positive Metastatic Breast Cancer Patients Receiving Fulvestrant. Nature Portfolio, 2016.